Full name
EUROPHARMA RESEARCH & SCIENCE CENTER SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
Europharma M.Rachtan sp. z o.o.
Krzywa 6, 40-061 Katowice
TAX ID6342621895
Rate company:
Europharma M.Rachtan sp. z o.o.
TAX ID6342621895
KRS0000272387
Share capital50,000.00 zł
Not confirmed
address
Krzywa 6, 40-061 Katowice
Categories
Main category
Other categories
Register Data
NIP
6342621895
REGON
240543453
KRS
0000272387
Legal form
limited liability company
ALEO.com Registration Date
2019-11-26
Register Address
UL. KRZYWA 6, 40-061 KATOWICE
Date of registration in KRS
2007-02-01
Date of commencement of economic activity
2007-02-01
Act signature
RDF/673083/24/902
Pkd codes
72.11.Z - Research and experimental development on biotechnology
58 - Publishing activities
62 - Computer programming, consultancy and related activities
70.2 - Management consultancy activities
71.2 - Technical testing and analysis
73.1 - Advertising
74 - Other professional, scientific and technical activities
79 - Travel agency, tour operator and other reservation service and related activities
85.59.B - Other out-of-school forms of education, not elsewhere classified
86 - Human health activities
Payer VAT status
Active
Vat list bank account(s)
PL54 1140 1078 0000 3003 9500 2003 
PL05 1140 1078 0000 3003 9500 2012 PL97 1140 1078 0000 3003 9500 2005 PL86 1140 1078 0000 3003 9500 2009 PL81 1140 1078 0000 3003 9500 2002 PL70 1140 1078 0000 3003 9500 2006 PL43 1140 1078 0000 3003 9500 2007 PL27 1140 1078 0000 3003 9500 2004 PL16 1140 1078 0000 3003 9500 2008 PL11 1140 1078 0000 3003 9500 2001 PL88 1140 2017 0000 4902 0621 5356 PL87 1140 2004 0000 3112 0448 9167 Show more bank accounts from VAT list (9)
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale  | -0,1 | 0,6 | 0,6 | 7,3 |
Gross profit (loss) | 0,8 | 0,6 | 0,6 | -1,5 |
EBITDA | 0,9 | 0,6 | 0,6 | 3,2 |
Short time liabilities | 3,3 | 1,6 | 1 | -41,5 |
Other operating costs | 0 | 0 | 0 | 455,5 |
Equity capital | 1,9 | 2,5 | 2,9 | 18,2 |
Operating profit (EBIT) | 0,8 | 0,6 | 0,6 | 4,1 |
Assets | 5,3 | 4,1 | 3,9 | -5,6 |
Net profit (loss) | 0,8 | 0,6 | 0,6 | 1,4 |
Cash | 0 | 0,5 | 0,2 | -62,9 |
Net income from sale | 12,4 | 9,7 | 6,9 | -28,5 |
Liabilities and provisions for liabilities | 3,4 | 1,6 | 1 | -41,5 |
Working assets | 3,7 | 2,3 | 2,1 | -10,7 |
Other income costs | 0,9 | 0 | 0 | 135,4 |
Depreciation | 0 | 0 | 0 | -17,2 |
% | % | % | p.p. | |
Profitability of capital | 44,1 | 23,6 | 20,3 | -3,3 |
Equity capital to total assets | 35,7 | 60,2 | 75,3 | 15,1 |
Gross profit margin | 6,7 | 6,2 | 8,5 | 2,3 |
EBITDA Margin | 6,9 | 6,5 | 9,4 | 2,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 98 | 61 | 50 | -11 |
Current financial liquidity indicator | 1.1000161170959473 | 1.4277535676956177 | 2.1783015727996826 | 0,8 |
Net dept to EBITDA | 0.2534334361553192 | -0.7162759304046631 | -0.29872551560401917 | 0,4 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download doc01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdfShow more (1)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
